Total raised
$4.0M
Last: Seed 2024-09
Stage
Seed
Founded
2023
Headcount
8
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences
About
ZipBio utilizes generative artificial Intelligence to revolutionize the development of new therapeutics, addressing some of the most pressing unmet needs in medicine. By creating de novo genes and proteins, the company's solution distill multiple complex functions into compact, highly effective therapeutic molecules.
Funding history · 1 round · $4.0M total
2024-09
Seed
$4.0M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B